Circular RNAs: Biogenesis, Function and Role in Human Diseases.
Greene J, Baird AM, Brady L, Lim M, Gray SG, McDermott R, Finn SP. · 2017
Read Circular RNAs: Biogenesis, Function and Role in Human Diseases. by Greene J, Baird AM, Brady L, Lim M, Gray SG, McDermott R, Finn SP. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5459888.txt.
Introduction
Greene and co-authors review circular RNAs, looped molecules that regulate genes and mark disease. Their review appeared in Frontiers in Molecular Biosciences. Linear RNA has two free ends. Circular RNA joins those ends into a loop. The closed shape resists exonuclease attack. Circles are thus stable and abundant in cells. They were dismissed for decades as splicing errors. Sequencing revived interest in them recently.
Circles form by backsplicing of exons. Others derive from lariat introns. Many act as sponges for microRNAs. Others bind proteins and steer transcription. Tumors often show lowered circle levels. Three causes are proposed for that drop. Cancer translocations can create aberrant fusion circles. Those fusions link to drug resistance. Circles also travel inside exosomes. Some circles can even be translated into proteins. The authors see biomarkers and drug targets ahead.
Catalog record
| CREATOR | Greene J, Baird AM, Brady L, Lim M, Gray SG, McDermott R, Finn SP. |
|---|---|
| YEAR | 2017 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 60 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Circular RNAs: Biogenesis, Function and Role in Human Diseases By John Greene, Anne-Marie Baird, Lauren Brady, Marvin Lim, Steven G. Gray, Raymond McDermott, Stephen P. Finn Published in: Frontiers in Molecular Biosciences DOI: 10.3389/fmolb.2017.00038 ABSTRACT Circular RNAs (circRNAs) are currently classed as non-coding RNA (ncRNA) that, unlike linear RNAs, form covalently closed continuous loops and act as gene regulators in mammals. They were originally thought to represent errors in splicing and considered to be of low abundance, however, there is now an increased appreciation of their important function in gene regulation. circRNAs are differentially generated by backsplicing of exons or from lariat introns. Unlike linear RNA, the 3′ and 5′ ends normally present in an RNA molecule have been joined together by covalent bonds leading to circularization. Interestingly, they have been found to be abundant, evolutionally conserved and relatively stable in the cytoplasm. These features confer numerous potential functions to circRNAs, such as acting as miRNA sponges, or binding to RNA-associated proteins to form RNA-protein complexes that regulate gene transcription. It has been proposed that circRNA regulate gene expression at the transcriptional or post-transcriptional level by interacting with miRNAs and that circRNAs may have a role in regulating miRNA function in cancer initiation and progression. circRNAs appear to be more often downregulated in tumor tissue compared to normal tissue and this may be due to (i) errors in the back-splice machinery in malignant tissues, (ii) degradation of circRNAs by deregulated miRNAs in tumor tissue, or (iii) increasing cell proliferation leading to a reduction of circRNAs. circRNAs have been identified in exosomes and more recently, chromosomal translocations in cancer have been shown to generate aberrant fusion-circRNAs associated with resistance to drug treatments. In addition, though originally thought to be non-coding, there is now increasing evidence to suggest that select circRNAs can be translated into functional proteins. Although much remains to be elucidated about circRNA biology and mechanisms of gene regulation, these ncRNAs are quickly emerging as potential disease biomarkers and therapeutic targets in cancer. INTRODUCTION Non-coding RNAs (ncRNA), which include short microRNAs (miRNA), long non-coding RNAs (lncRNA) and circular RNAs (circRNA) make up 95% of total RNA in eukaryotic transcription, and are being increasingly appreciated to have an important function in gene regulation (Warner, 1999; Esteller, 2011; Jeck et al., 2013). circRNAs are generated from the backsplicing of exons, introns, or both to form exonic or intronic circRNAs (Jeck et al., 2013). The first examples of circRNA transcripts were first identified over 30 years ago, however at that time they were thought to represent errors in RNA splicing, but are now appreciated to have important functions in gene regulation (Sanger et al., 1976; Kos et al., 1986; Nigro et al., 1991; Cocquerelle et al., 1993; Jeck et al., 2013). It wasn't until recently that interest in circRNA research was re-established by Salzman et al. who identified circRNAs in RNA Sequencing (RNA-Seq) samples of cancer and non-cancer cell lines, and from patients with Acute Lymphoblastic Leukemia (ALL) (Salzman et al., 2012). This development has led to the identification of thousands of individual circRNAs that are endogenous to mammalian cells and are both highly stable and abundant in vivo compared to their linear counterparts (Jeck and Sharpless, 2014). More recently, advances in high-throughput sequencing, novel bioinformatics approaches and corresponding experimental validation, have proven that circRNAs actually represent a distinct class of ncRNAs (Jeck and Sharpless, 2014). Unlike linear RNA, the 3′ and 5′ ends in circRNA normally present in an RNA molecule have been joined together, forming a covalently closed continuous loop, which prevents degradation by RNA exonucleases. This confers stability on circRNAs and makes them very abundant in the cytoplasm (Jeck et al., 2013). It has been proposed that cellular levels of circRNAs may be regulated by either endonucleic activity or removal by exosomes (Lasda and Parker, 2016). Their high abundance, stability and evolutionary conservation between species suggests that they may have an important regulatory role and indeed, recent evidence suggests circRNAs appear to act as miRNA sponges, in part due to the competitive endogenous RNA (ceRNA) network (Hansen et al., 2013a). circRNAs have been shown to be tissue specific and to be expressed in pathological conditions, which has stimulated significant interest into their role in human disease and cancer (Salzman et al., 2013). Although their exact roles and mechanisms of gene regulation remain to be clarified, circRNAs may have potential as disease biomarkers and novel therapeutic targets. BIOGENESIS OF CIRCRNAS Canonical eukaryotic pre-mRNA splicing is catalyzed by the spliceosomal machinery to remove introns and join exons leading to the formation of a linear RNA transcript with 5′–3′ polarity (Chen and Yang, 2015). Most circRNAs are produced during backsplicing, which does not follow the canonical 5′–3′ order, and is generally catalyzed by either the spliceosomal machinery or by group I and II ribozymes (Vicens and Westhof, 2014). circRNAs are distinct from their linear counterparts because they lack the usual terminal structures (e.g., 5′ cap or a polyadenylated (poly(A)) tail) due to their closed covalent bonds (Memczak et al., 2013). Inhibition of the canonical spliceosome using isoginkgetin, a pre-mRNA splicing inhibitor, reduces circRNA levels as well as the levels of the spliced linear transcript, providing evidence for a role for the spliceosome in circRNA biogenesis (Starke et al., 2015). The expression of circRNA does not always correlate with the expression level of the linear transcript from which the circRNA is derived, indicating that expression of circRNA is regulated and that the spliceosome must be able to discriminate between forward splicing, i.e., canonical linear splicing and backsplicing (Chen and Yang, 2015). circRNAs may arise from exons or introns leading to the formation of three different types of circRNAs; exonic, intronic and exon-intron circRNAs (Jeck et al., 2013). The formation of exonic circRNAs are a result of pre-mRNA splicing when the 3′ splice donor attaches to the 5′ splice acceptor forming an exonic circRNA (Figure 1; Jeck et al., 2013; Jeck and Sharpless, 2014). In some cases, this happens with a single exon, whereas in others the start of an upstream exon splices to the end of a downstream exon, with the intervening RNA circularized, producing circRNAs from multiple exons. Alternatively, if the intron between the exons is retained, the resulting circular transcript is referred to as exon–intron circRNA (Li Z. et al., 2015). Finally, intronic circRNAs can be produced from intron lariats that are resistant to degradation by de-branching enzymes (Jeck et al., 2013; Li Z. et al., 2015). Intronic circRNAs contain a single unique 2′–5′ linkage that distinguishes them from exonic circRNAs (Jeck and Sharpless, 2014). The formation of intronic circRNAs relies on GU-rich sequences near the 5′ splice site and C-rich sequences near the branch point (Zhang et al., 2013). During the backsplicing process, the two segments bind into a circle first, the exonic and intronic sequences in the binding part are cut out by the spliceosome with the remaining introns brought together to form intronic circRNA. [Figure: circRNA splicing. circRNAs are created by non-canonical splicing process known as “backsplicing.” A downstream splice donor is joined to an upstream splice acceptor. circRNAs can be exonic, intronic or a combination of both. Colored bars = exons. Black lines = introns.] Recently, researchers have